Actions of glucagon‐like peptide‐1 receptor ligands in the gut-Reference-Cited by-同舟云学术

Actions of glucagon‐like peptide‐1 receptor ligands in the gut

Published:2021-08-04 Issue:4 Volume:179 Page:727-742
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Holst Jens Juul¹,Andersen Daniel Bjørklund¹,Grunddal Kaare Villum¹

Affiliation:

1. Department of Biomedical Sciences and NovoNordisk Foundation Center for Basic Metabolic Research, Faculty of Health Sciences University of Copenhagen Copenhagen Denmark

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15611

Reference133 articles.

1. Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers

2. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors

3. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes

4. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters

5. Peripheral motor action of glucagon-like peptide-1 through enteric neuronal receptors

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist;Gynecologic Oncology;2024-11

2. Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis;Journal of Neuroimmune Pharmacology;2024-07-23

3. From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists;Molecular Biology Reports;2024-07-23

4. Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases;Alimentary Pharmacology & Therapeutics;2024-05-30

5. The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer;Cancer and Metastasis Reviews;2024-05-27